GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells.
GADD153/CHOP is a DNA damage-inducible, nuclear leucine zipper protein that is capable of producing a G1-S arrest in fibroblastic cells and of dimerizing with and inhibiting CAAT/enhancer binding protein (C/EBP) activities. CHOP was induced in 32D cl3 myeloid cells exposed to methylmethane sulfonate (MMS), a DNA alkylating agent. The degree of induction was dependent upon the dose of MMS to which the cells were exposed. CHOP was not expressed, at least at similar levels, during 32D cl3 cell granulocytic differentiation or during their apoptosis upon growth factor withdrawal. High-level expression of exogenous CHOP in 32D cl3 cells markedly inhibited the trans-activation activities of endogenous C/EBPs. These cells proliferated in IL-3, although low-level ongoing apoptosis not observed with control cells was detected. When these cultures were transferred to granulocyte colony-stimulating factor (G-CSF), the majority of the cells underwent apoptosis, although the levels of CHOP did not increase. Similarly, 32D cl3 cells treated with doses of MMS sufficient to induce endogenous CHOP underwent apoptosis more rapidly when placed in G-CSF-containing, compared with interleukin 3 (IL-3)-containing, medium. However, induction of CHOP by MMS was similar in IL-3 and in G-CSF. The heightened sensitivity of 32D l13 cells to CHOP in G-CSF could result either from the loss of IL-3-specific signals or from increased expression of C/EBPs. Because myeloid leukemias express C/EBPalpha, induction of CHOP might contribute to their chemotherapy-induced apoptosis, and alterations in CHOP expression could contribute to their development of chemotherapy resistance.
Friedman
A D
AD
The Johns Hopkins Oncology Center, Division of Pediatric Oncology, Baltimore, Maryland 21287, USA.
D000818:Animals; D017209:Apoptosis; D001483:Base Sequence; D022762:CCAAT-Enhancer-Binding Proteins; D002454:Cell Differentiation; D002478:Cells, Cultured; D004249:DNA Damage; D017931:DNA Primers / Q000737:chemistry; D004268:DNA-Binding Proteins / Q000378:metabolism* / Q000502:physiology; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D006410:Hematopoiesis / Q000187:drug effects; D007377:Interleukin-3 / Q000494:pharmacology; D008741:Methyl Methanesulfonate; D051379:Mice; D008969:Molecular Sequence Data; D009687:Nuclear Proteins / Q000502:physiology; D012333:RNA, Messenger / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics; D051742:Transcription Factor CHOP; D014157:Transcription Factors / Q000378:metabolism*; D015533:Transcriptional Activation
D022762:CCAAT-Enhancer-Binding Proteins; D017931:DNA Primers; D004268:DNA-Binding Proteins; C497250:Ddit3 protein, mouse; D007377:Interleukin-3; D009687:Nuclear Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D014157:Transcription Factors; D016179:Granulocyte Colony-Stimulating Factor; D051742:Transcription Factor CHOP; D008741:Methyl Methanesulfonate